PMID: 376107May 1, 1979Paper

Metabolic response to surgery in the cancer patient: consequences of aggressive multimodality therapy

Cancer
M F Brennan

Abstract

The metabolic response to uncomplicated surgery in the patient undergoing primary therapy for malignancy is no different than the response to surgery of similar magnitude for benign disease. Hemodynamic, nutritional-endocrine, and convalescent changes are similar. However, with current aggressive approaches to the management of cancer, the patient often comes to surgery with evidence of major debilitating side effects from his progressive malignancy or from aggressive multimodality therapy. The surgeon must be aware of the consequences of the use of combination therapies on the expected metabolic response to surgery. Awareness of such problems such as the nutritional deficit will allow preventive methods to supercede metabolic salvage procedures.

References

Mar 1, 1978·Cancer·J A NortonS A Rosenberg
Feb 1, 1976·Metabolism: Clinical and Experimental·C L LongJ W Geiger
Jul 11, 1970·Lancet·R G GrawP I Terasaki
Nov 11, 1974·JAMA : the Journal of the American Medical Association·B R BistrianR Heddle
Jan 27, 1972·The New England Journal of Medicine·M E Grant, D J Prockop
Oct 1, 1974·Annals of Surgery·D W WilmoreB A Pruitt
Dec 1, 1974·Archives of Surgery·M M MeguidF D Moore
Apr 1, 1972·Annals of Surgery·J NiinikoskiT K Hunt
Sep 1, 1972·The Proceedings of the Nutrition Society·G F CahillW A Müller
Feb 1, 1973·Metabolism: Clinical and Experimental·P Felig
Feb 1, 1974·Annals of Surgery·C HeughanT K Hunt
Sep 1, 1969·The Journal of Trauma·J E Bennett, L W Thompson
Jan 1, 1969·Advances in Clinical Chemistry·D Cuthbertson, W J Tilstone
Sep 1, 1972·The Journal of Endocrinology·J M GibbsW A Macbeth
Jun 1, 1966·Journal of Chronic Diseases·G P Bodey
May 1, 1967·The Journal of Clinical Pharmacology and the Journal of New Drugs·T C Hall
Mar 1, 1968·The Journal of Pediatrics·P Holland, N H Holland
Feb 13, 1970·Science·P FeligG F Cahill
Mar 1, 1968·Annals of Surgery·H P Ehrlich, T K Hunt
Apr 1, 1968·The American Journal of Clinical Nutrition·F Grande
May 1, 1969·The American Journal of Physiology·A L Goldberg, H M Goodman
Nov 1, 1966·The Journal of Clinical Investigation·G F CahillD M Kipnis
Nov 1, 1967·The American Journal of Physiology·A L Goldberg
Oct 1, 1967·The Journal of Clinical Investigation·O E OwenG F Cahill
Nov 17, 1955·The New England Journal of Medicine·J E DUNPHY, K N UDUPA
Jul 31, 1958·The New England Journal of Medicine·L C EDWARDS, J E DUNPHY
Oct 1, 1958·The American Journal of Medicine·R A KRITZLER
Jun 21, 1960·Annals of the New York Academy of Sciences·L J OLDM GOLDSMITH
Jul 1, 1963·Journal of Chronic Diseases·G A HYMAN
Jul 1, 1963·Journal of Chronic Diseases·E FREIJ B BLOCK
Sep 26, 1963·Annals of the New York Academy of Sciences·W E ABBOTT, K ALBERTSEN
Apr 1, 1964·Acta Medica Scandinavica·K B JENSENJ BICHEL
Jul 5, 1965·JAMA : the Journal of the American Medical Association·I H KRAKOFF, R L MEYER

❮ Previous
Next ❯

Citations

Mar 1, 1986·Journal of the American Geriatrics Society·C HardyL Balducci
Jan 1, 1985·American Journal of Hematology·L Balducci, C Hardy
Aug 1, 1984·Clinical Otolaryngology and Allied Sciences·C Pichard, M Roulet
Feb 1, 1986·Seminars in Oncology Nursing·A M Lindsey
Aug 13, 1981·The New England Journal of Medicine·M F Brennan
Jul 14, 1998·JPEN. Journal of Parenteral and Enteral Nutrition·E Svanberg
Sep 1, 1990·JPEN. Journal of Parenteral and Enteral Nutrition·J M DalyM H Torosian
Jun 1, 1982·Zeitschrift für Ernährungswissenschaft·G Ollenschläger
Dec 1, 1982·Nutrition Reviews·J van Eys

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.